1. Home
  2. OPTH vs CTSO Comparison

OPTH vs CTSO Comparison

Compare OPTH & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optimi Health Corp. Common Shares

OPTH

Optimi Health Corp. Common Shares

HOLD

Current Price

$3.25

Market Cap

28.9M

Sector

N/A

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$5.35

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPTH
CTSO
Founded
2020
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9M
23.9M
IPO Year
2024
2008

Fundamental Metrics

Financial Performance
Metric
OPTH
CTSO
Price
$3.25
$5.35
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.25
AVG Volume (30 Days)
25.4K
★ 55.7K
Earning Date
12-08-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
★ N/A
N/A
Revenue
N/A
★ $22,503,908.00
Revenue This Year
$56.17
$4.91
Revenue Next Year
$82.70
$13.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$3.04
$0.30
52 Week High
$5.45
$7.44

Technical Indicators

Market Signals
Indicator
OPTH
CTSO
Relative Strength Index (RSI) 27.97 63.40
Support Level $3.04 $2.88
Resistance Level $5.21 $7.44
Average True Range (ATR) 0.32 0.64
MACD -0.04 0.18
Stochastic Oscillator 10.00 63.59

Price Performance

Historical Comparison
OPTH
CTSO

About OPTH Optimi Health Corp. Common Shares

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: